Tribble Diane L. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Mar 2, 2011
Insider Transaction Report
Form 4
Tribble Diane L.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2011-03-01+220,000→ 220,000 totalExercise: $14.84Exp: 2021-03-01→ Common Stock (220,000 underlying)
Footnotes (2)
- [F1]The stock option award has an exercise price equal to the fair market value of Aergerion Pharmaceuticals, Inc.'s common stock on the date of grant, March 1, 2011.
- [F2]60% of the shares of common stock underlying this stock option vest in equal monthly installments over a four year period commencing immediately upon the date of hire, February 17, 2011; and 40% of the shares of common stock underlying this stock option vest in equal monthly installments over a four year period commencing upon marketing approval of Lomitapide by the U.S. Food and Drug Administration.